giantsight

© giantsight

FAQTermsPrivacy
BAKER BROS. ADVISORS LP
13F Filing

BAKER BROS. ADVISORS LP

Healthcare-focused investment firm with deep biotech expertise.

Period2026.04.01 ~ 2026.06.30
Filed2026.08.14
Filing
Current Portfolio
$19.96B
Reported total portfolio value per 13F filing
Previous Portfolio
$17.42B
Change
+14.58%

Holdings

Scroll
#Company% of PortfolioActivity
Market Value
SharesChangeSector
1
Incyte Corporation
INCY
Incyte Corporation
17.48%
Increased
$3.49B
30,762,330
+17,918
Health Care
2
BeOne Medicines Ltd.
ONC
BeOne Medicines Ltd.
12.57%
Increased
$2.51B
8,801,567
+2,514
Health Care
3
Revolution Medicines, Inc.
RVMD
Revolution Medicines, Inc.
10.74%
Increased
$2.14B
11,443,357
+1,888,000
Health Care
4
Madrigal Pharmaceuticals, Inc.
MDGL
Madrigal Pharmaceuticals, Inc.
5.77%
Increased
$1.15B
2,143,131
+1,430
Health Care
5
ACADIA Pharmaceuticals Inc.
ACAD
ACADIA Pharmaceuticals Inc.
5.44%
Increased
$1.09B
42,912,904
+16,214
Health Care
6
Kymera Therapeutics, Inc.
KYMR
Kymera Therapeutics, Inc.
4.97%
-
$993M
8,657,242
-
Health Care
7
Insmed Incorporated
INSM
Insmed Incorporated
4.70%
Increased
$938M
8,796,111
+1,375,000
Health Care
8
Celcuity Inc.
CELC
Celcuity Inc.
4.15%
-
$828M
7,915,792
-
Health Care
9
Kodiak Sciences Inc.
KOD
Kodiak Sciences Inc.
3.89%
-
$776M
19,919,186
-
Health Care
10
Rhythm Pharmaceuticals, Inc.
RYTM
Rhythm Pharmaceuticals, Inc.
3.12%
-
$622M
5,604,483
-
Health Care

Portfolio Changes

Buy Positions

New Buy

  • Faeth Therapeutics, Inc.
    SNSEFaeth Therapeutics, Inc.

    Current 0.16%

    +1,286,411Shares

  • Cytokinetics, Incorporated
    CYTKCytokinetics, Incorporated

    Current 0.09%

    +211,267Shares

  • Intellia Therapeutics, Inc.
    NTLAIntellia Therapeutics, Inc.

    Current 0.08%

    +930,232Shares

  • Parabilis Medicines, Inc.
    Parabilis Medicines, Inc.

    Current 0.07%

    +500,000Shares

  • Avalyn Pharma Inc.
    Avalyn Pharma Inc.

    Current 0.06%

    +350,000Shares

Additional Buy

  • Incyte Corporation
    INCYIncyte Corporation

    +0.06%

    +17,918Shares

  • BeOne Medicines Ltd.
    ONCBeOne Medicines Ltd.

    +0.03%

    +2,514Shares

  • Revolution Medicines, Inc.
    RVMDRevolution Medicines, Inc.

    +19.76%

    +1,888,000Shares

  • Madrigal Pharmaceuticals, Inc.
    MDGLMadrigal Pharmaceuticals, Inc.

    +0.07%

    +1,430Shares

  • ACADIA Pharmaceuticals Inc.
    ACADACADIA Pharmaceuticals Inc.

    +0.04%

    +16,214Shares

Sell Positions

Full Exit

  • Abivax S.A.
    ABVXAbivax S.A.

    Full Exit

    0Shares

  • Spyre Therapeutics, Inc.
    SYRESpyre Therapeutics, Inc.

    Full Exit

    0Shares

  • Centessa Pharmaceuticals plc
    CNTACentessa Pharmaceuticals plc

    Full Exit

    0Shares

  • Immunocore Holdings plc
    IMCRImmunocore Holdings plc

    Full Exit

    0Shares

  • Contineum Therapeutics, Inc.
    CTNMContineum Therapeutics, Inc.

    Full Exit

    0Shares

Partial Exit

  • Summit Therapeutics Inc.
    SMMTSummit Therapeutics Inc.

    -9.91%

    -3,604,715Shares

  • Immunovant, Inc.
    IMVTImmunovant, Inc.

    -0.42%

    -22,661Shares

  • Roivant Sciences Ltd.
    ROIVRoivant Sciences Ltd.

    -3.10%

    -150,892Shares

  • Edgewise Therapeutics, Inc.
    EWTXEdgewise Therapeutics, Inc.

    -43.71%

    -2,874,221Shares

  • Immatics N.V.
    IMTXImmatics N.V.

    -12.90%

    -1,408,128Shares

Other Investor Portfolios

Explore portfolios of other popular investors

BERKSHIRE HATHAWAY INC

BERKSHIRE HATHAWAY INC

Filed: May 15, 2026

View Full Portfolio
National Pension Service

National Pension Service

Filed: May 12, 2026

View Full Portfolio
Duquesne Family Office LLC

Duquesne Family Office LLC

Filed: May 15, 2026

View Full Portfolio
Situational Awareness LP

Situational Awareness LP

Filed: May 18, 2026

View Full Portfolio
Pershing Square Capital Management, L.P.

Pershing Square Capital Management, L.P.

Filed: May 15, 2026

View Full Portfolio